Oxaliplatin desensitization for ovarian cancer in pregnancy: A case report
Kaitlin Nicholson,
Lily Jia,
Margaret Rowe,
Katharine Esselen,
Naima Joseph,
Chloe A. Zera,
Timothy Lax,
Meghan Shea
Affiliations
Kaitlin Nicholson
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Corresponding author at: 330 Brookline Ave, Boston, MA 02215, United States.
Lily Jia
Harvard Medical School, Boston, MA, United States; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, United States
Margaret Rowe
Department of Medicine, Penn Medicine, Philadelphia, PA, United States
Katharine Esselen
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States
Naima Joseph
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Boston Medical Center/Boston University, Boston, MA, United States
Chloe A. Zera
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States
Timothy Lax
Department of Medicine, University of Massachusetts Memorial Health, Worcester, MA, United States
Meghan Shea
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, United States
